Although germline BRCA1 and BRCA2 (BRCA1/2) pathogenic variants account for a large proportion of Hereditary Breast and Ovarian Cancer (HBOC), a Scottish study on BRCA1/2 testing in ovarian cancer revealed that 48% of pathogenic variants did not fulfil family history criteria for testing7. This evidence concerns the gene BRCA2 and ovarian cancer.